miércoles, 18 de octubre de 2023

CDER soliciting comments regarding clinical trial innovation

https://www.fda.gov/drugs/drug-safety-and-availability/cder-soliciting-comments-regarding-clinical-trial-innovation?utm_medium=email&utm_source=govdelivery

No hay comentarios: